Grant of Options

RNS Number : 8780Z

Faron Pharmaceuticals Oy

22 May 2019

 

Faron Pharmaceuticals Ltd

("Faron" or the "Company")

Grant of options

TURKU - FINLAND, 22 May 2019 - Faron (LON: FARN), the clinical stage biopharmaceutical company, announces that on 21 May 2019 the Board of Faron confirmed the grant of a total of 460,000 D options over ordinary shares in the Company ("Options") under the Faron 2015 Option Plan. The Options have been allocated under the Faron 2015 Option Plan and are exercisable between 8 October 2018 and 30 September 2021 at an exercise price of 109 euro cents per share. The exercise price is calculated based on the average share price between 1 July and 30 September 2018. The terms of the 2015 Option Plan, are as described in the Company's Admission Document (available on the Company's website) as amended at the Company's 2017 annual general meeting, details of which were announced on 16 May 2017.

The granted 460,000 Options entitle the option holders to subscribe for a total of 460,000 new ordinary shares in the Company, if exercised in full, and represent 1.2% of the fully-diluted ordinary share capital of the Company.

Included in the number of Options granted are the following Options which were issued to Directors and other persons discharging managerial responsibilities ("PDMRs"):

Director	Options granted
Markku Jalkanen	80,000
Frank Armstrong	40,000
Yrjö E K Wichmann	30,000
Matti Manner	20,000
Leopoldo Zambeletti	20,000
Gregory Brown	20,000
John Poulos	20,000
Total Directors	230,000
PDMRs
Matti Karvonen	30,000
Jami Mandelin	30,000
Maria Lahtinen	25,000
Juho Jalkanen	30,000
Pessi Honkasalo	20,000
Total PDMRs	135,000

For more information please contact:

Faron Pharmaceuticals Ltd

Dr Markku Jalkanen, Chief Executive Officer

[e-mail] 

Consilium Strategic Communications

Mary-Jane Elliott, David Daley, Lindsey Neville 

Phone: [phone]

E-mail: [e-mail]

Panmure Gordon (UK) Limited, Nomad and Broker

Emma Earl, Freddy Crossley (Corporate Finance)

James Stearns (Corporate Broking)

Phone: [phone]

Westwicke Partners, IR (US)

Chris Brinzey

Phone: [phone]

E-Mail: [e-mail]

About Faron Pharmaceuticals Ltd

Faron (AIM:FARN) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy. The Company's lead candidate Traumakine, to prevent vascular leakage and organ failures, is currently the only treatment for Acute Respiratory Distress Syndrome (ARDS) undergoing Phase III clinical trials and in 2017 received advice from US FDA to proceed directly to BLA submission following completion of EU and Japanese Phase III studies.  There is currently no approved pharmaceutical treatment for ARDS. An additional European Phase II Traumakine trial is underway for the Rupture of Abdominal Aorta Aneurysm ("RAAA"). Faron's second candidate Clevegen is a ground breaking pre-clinical anti-Clever-1 antibody. Clevegen has the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development. This novel macrophage-directed immuno-oncology switch called Turn-on-your-Immunity or Turn-It may be used alone or in combination with other immune checkpoint molecules for the treatment of cancer patients. Faron is based in Turku, Finland. Further information is available at  www.faron.com

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Markku Jalkanen
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	80,000
d.	Aggregated information - Aggregated Volume - Price	80,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Frank Armstrong
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	40,000
d.	Aggregated information - Aggregated Volume - Price	40,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Yrjö E K Wichmann
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	30,000
d.	Aggregated information - Aggregated Volume - Price	30,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Matti Manner
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	20,000
d.	Aggregated information - Aggregated Volume - Price	20,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Leopoldo Zambeletti
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	20,000
d.	Aggregated information - Aggregated Volume - Price	20,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Gregory Brown
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	20,000
d.	Aggregated information - Aggregated Volume - Price	20,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	John Poulos
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	20,000
d.	Aggregated information - Aggregated Volume - Price	20,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Matti Karvonen
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	30,000
d.	Aggregated information - Aggregated Volume - Price	30,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Jami Mandelin
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	30,000
d.	Aggregated information - Aggregated Volume - Price	30,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Maria Lahtinen
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	25,000
d.	Aggregated information - Aggregated Volume - Price	25,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Juho Jalkanen
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	30,000
d.	Aggregated information - Aggregated Volume - Price	30,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Pessi Honkasalo
2	Reason for notification
a.	Position/Status	Person discharging managerial responsibilities
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Faron Pharmaceuticals Oy
b.	LEI	7437009H31TO1DC0EB42
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Options over ordinary shares ISIN: FI4000153309
b.	Nature of the transaction	Grant of options made pursuant to the Faron 2015 Option Plan exercisable at 109 Euro cents per Ordinary Share
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	25,000
d.	Aggregated information - Aggregated Volume - Price	25,000 Nil
e.	Date of the transaction	21 May 2019
f.	Place of the transaction	Turku

 

END

 

 

DSHSEAFFEFUSELI